Polypharmakos is a venture from the Royal Botanic Gardens, Kew, and Cambridge University that is exploring the world's largest plant and fungi extract libraries to look for novel ways to support healthy longevity Our first focus area is inflammaging, as the age-related decline of how we manage inflammation is linked to many of major diseases affecting humanity. We believe many novel therapies can be found in the natural world, and we are using our ethnobotanical knowledge, and advanced AI-screening, to look for new, safe and effective approaches from within our extract libraries.
| Website | http://www.polypharmakos.com |
| Revenue | $3 million |
| Employees | 5 (1 on RocketReach) |
| Founded | 2016 |
| Phone | +1 783-180-0683 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+8 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Business Services |
| Keywords | Plant Extracts, Healthy Aging, Natural Compounds, Longevity Research, Anti Inflammatory, Plant Based Medicine, Aging Research, Bioactive Compounds, Inflammation Research, Botanical Extracts, Novel Therapeutics, Drug Discovery, Nutraceuticals, Phytochemicals, Immunomodulation, Functional Medicine, Alternative Medicine, Herbal Medicine |
| Competitors | Bristol Myers Squibb, Roche, Novartis, Pfizer, AstraZeneca, Merck & Co., Inc., Sanofi, Johnson & Johnson, Amgen, Gilead Sciences +41 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular Polypharmakos employee's phone or email?
The Polypharmakos annual revenue was $3 million in 2026.
Adam Kelliher is the Co-Founder of Polypharmakos.
1 people are employed at Polypharmakos.
The NAICS codes for Polypharmakos are [541, 54, 541713, 54171, 5417].
The SIC codes for Polypharmakos are [873, 87].